A Smartphone Intervention to Promote Time Restricted Eating Reduces Body Weight and Blood Pressure in Adults with Overweight and Obesity: A Pilot Study

The goal of this study was to test the feasibility of time restricted eating (TRE) in adults with overweight and obesity. Participants (n = 50) logged all eating occasions (>0 kcal) for a 2-week run-in period using a smartphone application. Participants with eating duration >= 14 h enrolled in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nutrients 2021-06, Vol.13 (7), p.2148, Article 2148
Hauptverfasser: Prasad, Malini, Fine, Keenan, Gee, Allen, Nair, Nandini, Popp, Collin J., Cheng, Bin, Manoogian, Emily N. C., Panda, Satchidananda, Laferrere, Blandine
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The goal of this study was to test the feasibility of time restricted eating (TRE) in adults with overweight and obesity. Participants (n = 50) logged all eating occasions (>0 kcal) for a 2-week run-in period using a smartphone application. Participants with eating duration >= 14 h enrolled in an open label, non-randomized, prospective 90-day TRE intervention, with a self-selected reduced eating window of 10 h. No dietary counseling was provided. Changes in anthropometrics, eating patterns and adherence after TRE were analyzed using t-tests or Wilcoxon Rank-Sum Test. The mean duration of the baseline eating window was 14 h 32 m +/- 2 h 36 m (n = 50) with 56% of participants with duration >= 14 h. TRE participants (n = 16) successfully decreased their eating window from 16 h 04 m +/- 1 h 24 m to 11 h 54 m +/- 2 h 06 m (p < 0.001), and reduced the number of daily eating occasions by half (p < 0.001). Adherence to logging and to the reduced eating window was 64% +/- 22% and 47% +/- 19%, respectively. TRE resulted in decreases in body weight (-2.1 +/- 3.0 kg, p = 0.017), waist circumference (-2.2 +/- 4.6 cm, p = 0.002) and systolic blood pressure (-12 +/- 11 mmHg, p = 0.002). This study demonstrates the feasibility and efficacy of TRE administered via a smartphone, in adults with overweight and obesity.
ISSN:2072-6643
2072-6643
DOI:10.3390/nu13072148